Related Experiment Videos
Pseudomyxoma peritonei: case report and review of the literature
D H Toro1, L I Reyes, J Velázquez
1Medical Service, Veterans Administration Medical Center, San Juan, Puerto Rico.
Abstract:
Pseudomyxoma peritonei is a rare entity manifested by implants of a mucinous gelatinous material arising from either the appendix or ovary and involves the peritoneal cavity, peritoneum and omentum. Preoperative diagnosis is feasible by means of radiographic studies. The main step in the treatment is debulking surgery with appendectomy, bilateral oophorectomy and omentectomy. Adjuvant radiotherapy and chemotherapy has been used. Long term survival is around 54% at five years. Here we present a case of a ruptured mucocele of the appendix and pseudomyxoma who presents as massive increase in the abdominal girth of two years evolution.
Insights
Pseudomyxoma peritonei, a rare condition of mucinous implants, can be diagnosed radiographically. Treatment involves surgery, with appendectomy and oophorectomy, and survival rates around 54% at five years.
Area of Science:
- Gastroenterology and Surgical Oncology
Background:
- Pseudomyxoma peritonei (PMP) is a rare clinical entity characterized by mucinous gelatinous material implants.
- These implants originate from the appendix or ovary, involving the peritoneal cavity, peritoneum, and omentum.
Observation:
- Preoperative diagnosis of PMP is achievable through radiographic studies.
- This case highlights a ruptured mucocele of the appendix leading to PMP.
Findings:
- The primary treatment for PMP is cytoreductive surgery, including appendectomy, bilateral oophorectomy, and omentectomy.
- Adjuvant radiotherapy and chemotherapy are also utilized in management.
- Long-term survival rates for PMP are approximately 54% at five years.
Implications:
- This case underscores the importance of considering PMP in patients with massive abdominal distension.
- Early diagnosis and surgical intervention are critical for improving patient outcomes in PMP.